HIGHLIGHTS
- who: Swati Rajput et al. from the University of Arkansas for Medical Sciences, United States have published the Article: Efficacy of antiresorptive agents bisphosphonates and denosumab in mitigating hypercalcemia and bone loss in primary hyperparathyroidism: A systematic review and meta-analysis, in the Journal: (JOURNAL)
- what: Four studies were excluded from this meta-analysis because of the following reasons; the types of BP were not mentioned, data were not presented in the required format, and the treatment duration was five years. In this meta-analysis, the authors focused on the effect of BPs and denosumab . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.